To keep up with the latest from FIP, follow us on social media!
Insights into antimicrobial resistance (AMR) and antimicrobial stewardship (AMS) in the management of respiratory diseases in the USA are given in a report from FIP today. A FIP insight board gathered at the FIP congress in September 2023 discussed respiratory infection management post COVID-19, pharmacist-led AMS programmes, diagnostic services, patient and healthcare professional education and the One Health approach in the US context. Unique challenges related to point-of-care testing, collaboration with other healthcare professionals and reimbursement of services, and ideas for fostering collaboration with different sectors are presented in the report.